Pulse Biosciences (PLSE) Accumulated Depreciation & Amortization (2015 - 2025)

Pulse Biosciences has reported Accumulated Depreciation & Amortization for 11 years, with the latest figure at $4.4 million in Q4 2025.

• For the quarter ending Q4 2025, Accumulated Depreciation & Amortization rose 10.23% year-over-year to $4.4 million; the trailing twelve-month figure through Dec 2025 stood at $4.4 million (up 10.23% YoY), and the FY2025 full-year result was $4.4 million, up 10.23% from the prior year.
• Accumulated Depreciation & Amortization for Q4 2025 stood at $4.4 million, up from $4.3 million in the prior quarter.
• The five-year high for Accumulated Depreciation & Amortization was $4.4 million in Q4 2025, with the low at $2.0 million in Q1 2021.
• Average Accumulated Depreciation & Amortization over 5 years is $3.3 million, with a median of $3.3 million recorded in 2021.
• Year-over-year, Accumulated Depreciation & Amortization soared 73.8% in 2021 and dropped 11.32% in 2022.
• Tracing PLSE's Accumulated Depreciation & Amortization over 5 years: stood at $3.3 million in 2021, then decreased by 11.32% to $3.0 million in 2022, then gained by 17.71% to $3.5 million in 2023, then increased by 14.15% to $4.0 million in 2024, then advanced by 10.23% to $4.4 million in 2025.
• The last three Accumulated Depreciation & Amortization figures came in at $4.4 million (Q4 2025), $4.3 million (Q3 2025), and $4.2 million (Q2 2025), per Business Quant data.

Peer Comparison